Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function
- 20 July 2007
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 74 (8) , 1182-1191
- https://doi.org/10.1016/j.bcp.2007.07.019
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Discovery of the α7 Nicotinic Acetylcholine Receptor Agonists. (R)-3‘-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5‘-[1‘,3‘]oxazolidin-2‘-one as a Novel, Potent, Selective, and Orally Bioavailable LigandJournal of Medicinal Chemistry, 2005
- Improved P50 Auditory Gating With Ondansetron in Medicated Schizophrenia PatientsAmerican Journal of Psychiatry, 2005
- Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophreniaBehavioural Brain Research, 2004
- Linkage of M5 Muscarinic and α7-Nicotinic Receptor Genes on 15q13 to SchizophreniaNeuropsychobiology, 2004
- Nicotinic receptors and schizophreniaCurrent Medical Research and Opinion, 2004
- Inhibitory Action of Clozapine on Rat Ventral Tegmental Area Dopamine Neurons Following Increased Levels of Endogenous Kynurenic AcidNeuropsychopharmacology, 2003
- The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophreniaJournal of Chemical Neuroanatomy, 2000
- AR-R 17779, an α7 nicotinic agonist, improves learning and memory in ratsBehavioural Pharmacology, 1999
- Nicotinic System Involvement in Alzheimer??s and Parkinson??s DiseasesDrugs & Aging, 1997
- Cholinergic—dopaminergic interactions in radial-arm maze performanceBehavioral and Neural Biology, 1988